IDYA · IDEAYA Biosciences, Inc. · Executive Compensation

$35.36 +1.55 (+4.58%)

Russell 2000 member Rebalance outlook locked

Market Cap

$3.26B

96.49M

Volume · Oct 20 953.3K Avg daily vol (3M) 788.92K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	President and Chief Executive Officer	$700,000	—	—	$8,418,840	$378,000	$15,800	$9,512,640
Joshua Bleharski	Chief Financial Officer	$333,333	$150,000	—	$3,463,975	$186,000	$14,014	$4,147,322
Darrin M. Beaupre	M.D., Ph.D. Chief Medical Officer	$526,500	—	—	$2,595,809	$196,000	$15,800	$3,334,109
Michael White	Chief Scientific Officer	$519,000	—	—	$2,595,809	$193,500	$15,800	$3,324,109
Andres Ruiz Briseno	Chief Accounting Officer	$417,000	—	—	$1,052,355	$168,000	$15,800	$1,653,155
Douglas B. Snyder	Chief Legal Officer	$440,000	—	—	$463,036	$164,000	$64,523	$1,131,560

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	President and Chief Executive Officer	$646,000	—	—	$15,946,272	$323,000	$15,600	$16,930,872
Darrin M. Beaupre	M.D., Ph.D. Chief Medical Officer	$501,500	—	—	$5,315,424	$228,100	$15,600	$6,060,624
Michael White	Chief Scientific Officer	$489,500	—	—	$4,650,996	$223,300	$15,600	$5,379,396
Jason S. Throne	Former Chief Legal Officer	$286,210	—	—	$4,169,286	—	$14,775	$4,470,270
Stuart C. Dorman	Chief Commercial Officer	$41,667	$100,000	—	$3,258,441	$20,000	$150	$3,420,258
Andres Ruiz Briseno	Chief Accounting Officer	$382,500	—	—	$2,823,819	$133,875	$15,600	$3,355,794

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	President and Chief Executive Officer	$598,000	—	—	$5,083,440	$299,000	$15,000	$5,995,440
Michael White	Chief Scientific Officer	$462,000	—	—	$2,096,919	$184,800	$15,000	$2,758,719
Paul A. Stone	Former Chief Financial Officer	$432,024	—	—	$1,779,204	—	$14,775	$2,226,003
Jason S. Throne	Former Chief Legal Officer	$417,000	—	—	$1,270,860	$166,800	$15,000	$1,869,660
Darrin M. Beaupre	M.D., Ph.D. Chief Medical Officer	$473,000	—	—	$1,143,774	$189,200	$3,377	$1,809,351
Andres Ruiz Briseno	Chief Accounting Officer	$345,000	—	—	$927,417	$125,125	$15,000	$1,412,542

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	President and Chief Executive Officer	$570,000	—	—	$2,475,304	$270,750	$10,950	$3,327,004
Darrin M. Beaupre	M.D., Ph.D. Chief Medical Officer	$52,487	$100,000	—	$2,380,122	—	$150	$2,532,759
Michael White	Chief Scientific Officer	$440,000	—	—	$880,637	$169,840	$4,009	$1,494,486
Paul A. Stone	Former Chief Financial Officer	$419,000	—	—	$880,637	$161,734	$10,950	$1,472,321

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	President and Chief Executive Officer	$543,600	—	—	$3,050,151	$244,620	$10,500	$3,848,871
Michael White	Chief Scientific Officer	$80,625	$180,000	—	$3,321,860	—	$375	$3,582,860
Paul A. Stone	Former Chief Financial Officer	$394,000	—	—	$1,251,344	$146,940	$10,500	$1,802,784

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	President and Chief Executive Officer	$509,800	—	—	$1,066,486	$191,175	$10,350	$1,777,811
Jason S. Throne	J.D.^(^^4)^ Senior Vice President, General Counsel, and Corporate Secretary	$332,500	—	—	$738,233	$89,513	$3,550	$1,163,796
Paul A. Stone	Senior Vice President and Chief Financial Officer	$374,500	—	—	$396,832	$123,585	$10,350	$905,267

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	President and Chief Executive Officer	$457,150	—	—	$1,398,696	$154,943	$10,200	$2,020,989
Julie Hambleton	Senior Vice President and Chief Medical Officer, Head of Development	$387,063	—	—	$180,964	$108,500	$10,200	$686,726
Michael P. Dillon	Senior Vice President and Chief Scientific Officer, Head of Research	$338,875	—	—	$226,205	$95,500	$10,200	$670,780
Paul A. Stone	Senior Vice President and Chief Financial Officer	$327,250	—	—	$180,964	$103,000	$1,800	$613,014

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yujiro Hata	President and Chief Executive Officer	$420,000	—	—	$1,687,701	$147,000	$8,000	$2,262,701
Julie Hambleton	Senior Vice President and Chief Medical Officer, Head of Development	$218,750	—	—	$512,217	$65,625	$1,050	$797,642
Michael P. Dillon	Senior Vice President and Chief Scientific Officer, Head of Research	$315,000	—	—	$244,039	$94,500	$4,506	$658,045

Executive changes

Person	Role	Change	Effective	Filed
Joshua Bleharski, Ph.D.	Chief Financial Officer and Principal Financial Officer	Appointed	2025-06-26	2025-06-27
Susan L. Kelley, M.D.	Board of Directors	Resigned	—	2025-04-02
Jason Throne	Chief Legal Officer and Secretary	Resigned	2024-07-11	2024-06-27
Paul A. Stone	Chief Financial Officer	Resigned	2023-11-10	2023-09-26
Andres Ruiz Briseno	Principal Accounting Officer	Appointed	2023-07-01	2023-07-03

Leadership

Yujiro Hata CEO, Board Member
Joshua Bleharski CFO
Joshua Bleharski, Ph.D. CFO
Andres Ruiz Briseno Chief Accounting Officer, Head of Investor Relations
Catherine J. Mackey Board Member
Catherine J. Mackey, Ph.D. Board Member
Garret Hampton Board Member
Jeffrey L. Stein Board Member
M. Garret Hampton Board Member
Scott W. Morrison Board Member
Terry J. Rosen Board Member
Wendy L. Yarno Board Member

Key facts CIK 1676725 CUSIP 45166A102 13F (30d) 22 filings 22 filers Visit website Investor relations